Literature DB >> 2952760

Characterization of protease cleavage sites involved in the formation of the envelope glycoprotein and three non-structural proteins of dengue virus type 2, New Guinea C strain.

A Biedrzycka, M R Cauchi, A Bartholomeusz, J J Gorman, P J Wright.   

Abstract

Amino terminal sequences of the envelope protein E and the three largest nonstructural proteins NS1, NS3, and NS5 of the New Guinea C strain of dengue virus type 2 (DEN-2) were obtained by nucleotide and protein sequencing. Clones were prepared containing cDNA of DEN-2 virus in the plasmid pUC8. The nucleotide sequences of viral cDNA inserts were determined and the cDNA of each clone positioned on the flavivirus genomic map by comparison of the deduced amino acid sequence with that of yellow fever virus. Radiolabelled E, NS1, NS3 and NS5 were purified by lectin affinity chromatography and preparative gel electrophoresis. Purified proteins were subsequently analysed by Edman degradation to establish the origins of the amino termini of these proteins in the deduced DEN-2 amino acid sequence. Thus the amino acid sequences surrounding the likely proteolytic cleavage sites used in the formation of these four proteins were determined. Of particular interest was the sequence containing the amino terminus of NS3, namely Lys-Lys-Gln-Arg-Ala-Gly where Ala is the first amino acid of NS3. Cleavage following one basic residue in the flavivirus polyprotein has not been reported previously.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2952760     DOI: 10.1099/0022-1317-68-5-1317

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

1.  Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins.

Authors:  B Falgout; M Pethel; Y M Zhang; C J Lai
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a.

Authors:  B Falgout; R Chanock; C J Lai
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

3.  Processing of dengue virus type 2 structural proteins containing deletions in hydrophobic domains.

Authors:  A Gruenberg; P J Wright
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

4.  Expression of the NS1 gene of dengue virus type 2 using vaccinia virus. Dimerisation of the NS1 glycoprotein.

Authors:  C R Parrish; W S Woo; P J Wright
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  In vitro processing of dengue virus type 2 nonstructural proteins NS2A, NS2B, and NS3.

Authors:  F Preugschat; C W Yao; J H Strauss
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

6.  Cleavage of dengue virus NS1-NS2A requires an octapeptide sequence at the C terminus of NS1.

Authors:  H Hori; C J Lai
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

7.  Upregulation of signalase processing and induction of prM-E secretion by the flavivirus NS2B-NS3 protease: roles of protease components.

Authors:  V F Yamshchikov; D W Trent; R W Compans
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  Sequence of the dengue virus type 2 (strain PR-159) NS1 gene and comparison with its vaccine derivative.

Authors:  H Leblois; P R Young
Journal:  Nucleic Acids Res       Date:  1993-04-11       Impact factor: 16.971

9.  Cleavage of the dengue virus polyprotein at the NS3/NS4A and NS4B/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A/NS4B may be processed by a cellular protease.

Authors:  A Cahour; B Falgout; C J Lai
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

10.  High-level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model.

Authors:  S C Jacobs; J R Stephenson; G W Wilkinson
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.